Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INNOVAGE HOLDING CORP.

(INNV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

InnovAge : Cowen Adjusts Price Target for InnovAge Holding to $13 From $17, Maintains Market Perform Rating

09/22/2021 | 01:30pm EST


© MT Newswires 2021
All news about INNOVAGE HOLDING CORP.
11/25SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Innov..
PR
11/15SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Innov..
PR
11/12InnovAge Appoints Patrick Blair as President - Form 8-K
PU
11/12INNOVAGE HOLDING CORP. : Change in Directors or Principal Officers, Regulation FD Disclosu..
AQ
11/12InnovAge Appoints Patrick Blair as President
GL
11/12InnovAge Holding Corp Appoints Patrick Blair as President
CI
11/11InnovAge to Bring PACE to Seniors in Terre Haute, IN, Area
AQ
11/10Piper Sandler Adjusts Price Target on InnovAge to $14 From $20, Reiterates Overweight R..
MT
11/09INNOVAGE HOLDING CORP. Management's Discussion and Analysis of Financial Condition and..
AQ
11/09INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2..
PU
More news
Analyst Recommendations on INNOVAGE HOLDING CORP.
More recommendations
Financials (USD)
Sales 2022 719 M - -
Net income 2022 28,3 M - -
Net cash 2022 656 M - -
P/E ratio 2022 36,4x
Yield 2022 -
Capitalization 1 031 M 1 031 M -
EV / Sales 2022 0,52x
EV / Sales 2023 0,42x
Nbr of Employees 1 800
Free-Float 14,0%
Chart INNOVAGE HOLDING CORP.
Duration : Period :
InnovAge Holding Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INNOVAGE HOLDING CORP.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 7,61 $
Average target price 15,17 $
Spread / Average Target 99,3%
EPS Revisions
Managers and Directors
Maureen Hewitt President, Chief Executive Officer & Director
Barbara K. Gutierrez Chief Financial Officer
Andrew J. Cavanna Chairman
Melissa Welch Chief Medical Officer
Alice Raia Chief Information Officer
Sector and Competitors